Praram 9 Hospital Future Growth

Future criteria checks 2/6

Praram 9 Hospital is forecast to grow earnings and revenue by 11.7% and 7.7% per annum respectively while EPS is expected to grow by 12.1% per annum.

Key information

11.7%

Earnings growth rate

12.1%

EPS growth rate

Healthcare earnings growth	10.0%
Revenue growth rate	7.7%
Future return on equity	n/a
Analyst coverage	Good
Last updated	23 May 2023

Recent future growth updates

No updates

Recent updates

Earnings and Revenue Growth Forecasts

THAMSE:PR9-F - Analysts future estimates and past financials data (THB Millions)
Date	Revenue	Earnings	Free Cash Flow	Cash from Op	Avg. No. Analysts
12/31/2025	5,118	715	786	1,068	3
12/31/2024	4,757	660	644	995	6
12/31/2023	4,413	587	558	901	6
3/31/2023	4,139	519	674	845	N/A
12/31/2022	4,150	568	730	893	N/A
9/30/2022	3,980	545	675	897	N/A
6/30/2022	3,665	481	637	885	N/A
3/31/2022	3,327	368	438	710	N/A
12/31/2021	3,026	249	336	588	N/A
9/30/2021	2,826	214	261	496	N/A
6/30/2021	2,767	204	205	498	N/A
3/31/2021	2,646	203	-54	434	N/A
12/31/2020	2,633	202	-316	424	N/A
9/30/2020	2,637	195	-478	384	N/A
6/30/2020	2,686	211	-608	359	N/A
3/31/2020	2,841	236	-523	444	N/A
12/31/2019	2,876	284	-349	490	N/A
9/30/2019	2,842	178	-616	520	N/A
6/30/2019	2,809	176	-510	511	N/A
3/31/2019	2,774	191	-366	514	N/A
12/31/2018	2,727	157	-337	480	N/A
9/30/2018	2,689	274	6	428	N/A
6/30/2018	2,620	268	-22	451	N/A
3/31/2018	2,543	266	-39	456	N/A
12/31/2017	2,455	262	-100	440	N/A
12/31/2016	2,259	267	N/A	N/A	N/A
12/31/2015	1,982	194	N/A	N/A	N/A
12/31/2014	1,794	162	N/A	N/A	N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: PR9-F's forecast earnings growth (11.7% per year) is above the savings rate (1.9%).

Earnings vs Market: PR9-F's earnings (11.7% per year) are forecast to grow slower than the TH market (18.8% per year).

High Growth Earnings: PR9-F's earnings are forecast to grow, but not significantly.

Revenue vs Market: PR9-F's revenue (7.7% per year) is forecast to grow faster than the TH market (5.3% per year).

High Growth Revenue: PR9-F's revenue (7.7% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: Insufficient data to determine if PR9-F's Return on Equity is forecast to be high in 3 years time

Discover growth companies

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2023/07/16 03:41
End of Day Share Price	2023/04/18 00:00
Earnings	2023/03/31
Annual Earnings	2022/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Praram 9 Hospital Public Company Limited is covered by 11 analysts. 6 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Charti Phrawphraikul	BofA Global Research
Narumon Ekasamut	Bualuang Securities PCL
Panjapon Taensricharoen	Bualuang Securities PCL